Shareholders Equity: The sum of preferred and common equity items.
Oragenics, Inc. (OGEN) had Shareholders Equity of $-0.21M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-10.57M |
|
-- |
|
-- |
|
$10.56M |
|
$-10.56M |
|
$-0.01M |
|
$-10.57M |
|
$-10.57M |
|
$-10.57M |
|
$-10.57M |
|
$-10.57M |
|
$-10.57M |
|
$-10.56M |
|
$-10.56M |
|
6.62M |
|
6.62M |
|
$-1.60 |
|
$-1.60 |
|
| Balance Sheet Financials | |
$1.47M |
|
-- |
|
-- |
|
$1.47M |
|
$1.68M |
|
-- |
|
-- |
|
$1.68M |
|
$-0.21M |
|
$-0.21M |
|
|
Shareholders Equity |
$-0.21M |
12.57M |
|
| Cash Flow Statement Financials | |
$-8.60M |
|
-- |
|
$5.98M |
|
$3.48M |
|
$0.86M |
|
$-2.62M |
|
$0.52M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.87 |
|
-- |
|
-- |
|
-- |
|
-1.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
4987.61% |
|
4987.57% |
|
-717.68% |
|
4987.57% |
|
$-0.02 |
|
$-1.30 |
|
$-1.30 |
|